AVIR Atea Pharmaceuticals, Inc. - common stock
$4.19
Price · May 20, 2026
Fundamentals as of May 12, 2026
52W Range
$3–$6
38% of range
Analyst Rating
BUY
9 analysts
Price Target
$9
+107% upside
P/E (TTM)
-1.8
ROE
-49.5%
Net Profit Margin
—
AVIR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.19
Market Cap
$279M
P/E (TTM)
-1.8
EPS (TTM)
$-1.94
Revenue (TTM)
—
Div Yield
—
ROE
-49.5%
Debt/Equity
—
52W Range
$3 – $6
AVIR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
2020-12-31
→
2021-12-31
EPS
$-1.94
2019-12-31
→
2025-12-31
Free Cash Flow
—
2020-12-31
→
2022-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AVIR
Peer Median
P/E (TTM)
-1.8
24.0
P/B
1.0
2.0
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AVIR
Peer Median
ROA
-40.6%
-22.8%
ROE
-49.5%
-24.5%
ROIC
-63.2%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AVIR
Peer Median
Current Ratio
7.8
7.8
Quick Ratio
2.4
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AVIR
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AVIR
Peer Median
AVIR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 3 33.3%
- Buy 4 44.4%
- Hold 2 22.2%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-05-16
Median
$10.00
Mean
$8.67
← Below all targets
$4.19
Low
$6.00
High
$10.00
Median target
$10.00
+138.7%
Mean target
$8.67
+106.8%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.02%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.57 | $-0.60 | 0.03% |
| Dec. 31, 2025 | $-0.57 | $-0.54 | -0.03% |
| Sept. 30, 2025 | $-0.53 | $-0.45 | -0.08% |
| June 30, 2025 | $-0.44 | $-0.42 | -0.02% |
| March 31, 2025 | $-0.40 | $-0.42 | 0.02% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| FULC | $753M | -9.6 | 2752.0% | — | -26.6% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| NMRA | $312M | -1.2 | — | — | -165.2% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $351M | $49M | |
| R&D Expense | $148M | $144M | $114M | $82M | $167M | $38M | |
| SG&A Expense | $33M | $49M | $50M | $49M | $46M | $22M | |
| Operating Expenses | $181M | $193M | $164M | $131M | $213M | $60M | |
| Operating Income | $-181M | $-193M | $-164M | $-131M | $138M | $-11M | |
| Pretax Income | $-165M | $-167M | $-135M | $-119M | $139M | $-11M | |
| Income Tax | $-6M | $925.0K | $1M | $-4M | $17M | · | |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| EPS (Basic) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 | $-0.51 | |
| EPS (Diluted) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 | |
| Shares (Basic) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 82,820,037 | 21,592,441 | |
| Shares (Diluted) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 88,249,243 | 21,592,441 | |
| EBITDA | $-181M | $-193M | $-164M | $-131M | $138M | $-11M |
Balance Sheet 20
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $65M | $144M | $188M | $764M | $850M | |
| Prepaid Expense | $9M | $8M | $12M | $14M | $8M | $8M | |
| Current Assets | $311M | $462M | $590M | $661M | $772M | $863M | |
| PP&E (Net) | $457.0K | $873.0K | $1M | $2M | $23.0K | $48.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $184.0K | $180.0K | |
| Accum. Depreciation | $2M | $1M | $689.0K | $273.0K | $161.0K | $132.0K | |
| Other Non-current Assets | $3M | $197.0K | $1M | $1M | $466.0K | $107.0K | |
| Total Assets | $315M | $465M | $595M | $667M | $773M | $864M | |
| Accounts Payable | $13M | $4M | $4M | $3M | $5M | $60.0K | |
| Current Liabilities | $40M | $19M | $32M | $18M | $57M | $316M | |
| Capital Leases | $0 | $842.0K | $2M | $2M | · | · | |
| Other Non-current Liabilities | · | · | · | · | $6M | $36.0K | |
| Total Liabilities | $40M | $26M | $40M | $26M | $63M | $316M | |
| Common Stock | $78.0K | $84.0K | $83.0K | $83.0K | $83.0K | $82.0K | |
| Paid-in Capital | $798M | $803M | $751M | $701M | $654M | $613M | |
| Retained Earnings | $-523M | $-364M | $-196M | $-60M | $56M | $-65M | |
| AOCI | $174.0K | $233.0K | $207.0K | $-684.0K | · | · | |
| Stockholders' Equity | $275M | $439M | $555M | $641M | $710M | $548M | |
| Liabilities + Equity | $315M | $465M | $595M | $667M | $773M | $864M | |
| Shares Outstanding | 78,126,796 | 84,463,059 | 83,435,513 | 83,287,639 | 83,102,730 | 82,436,937 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $416.0K | $416.0K | $260.0K | $29.0K | $19.0K | |
| Stock-based Comp | $21M | $52M | $49M | $47M | $40M | $7M | |
| Deferred Tax | $-6M | $0 | · | · | · | $0 | |
| Operating Cash Flow | $-132M | $-135M | $-85M | $-121M | $-87M | $297M | |
| CapEx | · | · | · | $2M | $4.0K | $26.0K | |
| Investing Cash Flow | $189M | $56M | $40M | $-455M | $-4.0K | $-26.0K | |
| Stock Issued | · | · | · | · | $1M | $27.0K | |
| Stock Repurchased | $26M | $0 | · | · | · | · | |
| Net Stock Activity | $-26M | · | · | · | $1M | $27.0K | |
| Financing Cash Flow | $-26M | $267.0K | $257.0K | $370.0K | $1M | $532M | |
| Net Change in Cash | $31M | $-79M | $-45M | $-576M | $-86M | $828M | |
| Free Cash Flow | · | · | · | $-123M | $-87M | $297M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 39.4% | -22.7% | |
| Net Margin | · | · | · | · | 34.5% | -22.5% | |
| Pretax Margin | · | · | · | · | 39.4% | · | |
| EBITDA Margin | · | · | · | · | 39.4% | -22.7% | |
| ROA | -40.6% | -31.8% | -21.6% | -16.1% | 14.8% | -2.5% | |
| ROE | -49.5% | -37.5% | -23.9% | -17.8% | 18.8% | -4.7% | |
| ROIC | -63.2% | -44.2% | -29.8% | -19.8% | 17.0% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 | 2.7 | |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 | 2.7 |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | 0.1 |
Growth Rates 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 622.5% | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $351M | $49M | |
| Net Income TTM | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| Market Cap | $279M | $283M | $254M | $401M | $743M | $3.44B | |
| P/E | -1.8 | -1.7 | -1.9 | -3.5 | 6.5 | -81.9 | |
| P/S | · | · | · | · | 2.1 | 70.8 | |
| P/B | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Tangible Book | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Cash Flow | -2.1 | -2.1 | -3.0 | -3.3 | -8.5 | 11.6 | |
| P / FCF | · | · | · | -3.3 | -8.5 | 11.6 | |
| Earnings Yield | -54.3% | -59.7% | -53.4% | -28.9% | 15.3% | -1.2% |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $41M | $48M | $38M | $32M | $30M | $26M | $26M | $35M | $58M | $35M | $28M | $22M | $29M | $28M | $5M | $20M | |
| SG&A Expense | $7M | $7M | $7M | $9M | $9M | $13M | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $11M | $12M | |
| Operating Expenses | $48M | $55M | $46M | $41M | $39M | $39M | $37M | $47M | $70M | $47M | $41M | $35M | $42M | $40M | $16M | $32M | |
| Operating Income | $-48M | $-55M | $-46M | $-41M | $-39M | $-39M | $-37M | $-47M | $-70M | $-47M | $-41M | $-35M | $-42M | $-40M | $-16M | $-32M | |
| Pretax Income | $-45M | $-52M | $-42M | $-37M | $-34M | $-33M | $-31M | $-40M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-12M | $-31M | |
| Income Tax | $50.0K | $-7M | $196.0K | $207.0K | $203.0K | $225.0K | $226.0K | $243.0K | $231.0K | $349.0K | $221.0K | $251.0K | $197.0K | $123.0K | $-4M | $120.0K | |
| Net Income | $-45M | $-45M | $-42M | $-37M | $-34M | $-34M | $-31M | $-41M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-8M | $-31M | |
| EPS (Basic) | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | $-0.38 | |
| EPS (Diluted) | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | $-0.38 | |
| Shares (Basic) | 79,198,204 | -166,463,391 | 79,052,154 | 83,747,335 | 85,159,254 | -168,327,178 | 84,422,000 | 84,253,700 | 83,916,193 | -166,741,793 | 83,399,769 | 83,399,377 | 83,332,397 | -166,447,151 | 83,258,537 | 83,257,591 | |
| Shares (Diluted) | 79,198,204 | -166,463,391 | 79,052,154 | 83,747,335 | 85,159,254 | -168,327,178 | 84,422,000 | 84,253,700 | 83,916,193 | -166,741,793 | 83,399,769 | 83,399,377 | 83,332,397 | -166,447,151 | 83,258,537 | 83,257,591 | |
| EBITDA | $-48M | · | $-46M | $-41M | $-39M | · | $-37M | $-47M | $-70M | · | $-41M | $-35M | $-42M | · | $-16M | $-32M |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $96M | $77M | $88M | $119M | $65M | $98M | $243M | $161M | $144M | $138M | $214M | $183M | $188M | $176M | $684M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | · | |
| Prepaid Expense | $7M | $9M | $7M | $6M | $8M | $8M | $4M | $4M | $7M | $12M | $8M | $13M | $12M | $14M | $12M | $5M | |
| Current Assets | $263M | $311M | $336M | $386M | $434M | $462M | $487M | $506M | $549M | $590M | $603M | $621M | $632M | $661M | $682M | $689M | |
| PP&E (Net) | $353.0K | $457.0K | $561.0K | $665.0K | $769.0K | $873.0K | $977.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | $2M | · | · | · | $1M | · | · | · | $689.0K | · | · | · | $273.0K | · | · | |
| Other Non-current Assets | $3M | $3M | $5M | $4M | $4M | $197.0K | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | · | · | |
| Total Assets | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | $694M | |
| Accounts Payable | $9M | $13M | $4M | $9M | $7M | $4M | $6M | $5M | $21M | $4M | $395.0K | $4M | $700.0K | $3M | $1M | $14M | |
| Current Liabilities | $33M | $40M | $20M | $20M | $22M | $19M | $25M | $27M | $41M | $32M | $19M | $16M | $12M | $18M | $16M | $25M | |
| Capital Leases | · | $0 | $213.0K | $425.0K | $634.0K | $842.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Total Liabilities | · | $40M | $27M | $27M | $29M | $26M | $32M | $34M | $49M | $40M | $26M | $24M | $20M | $26M | $23M | $34M | |
| Common Stock | $80.0K | $78.0K | $78.0K | $81.0K | $85.0K | $84.0K | $84.0K | $84.0K | $84.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | |
| Paid-in Capital | $802M | $798M | $793M | $800M | $809M | $803M | $788M | $776M | $763M | $751M | $739M | $726M | $714M | $701M | $689M | $678M | |
| Retained Earnings | $-568M | $-523M | $-478M | $-436M | $-398M | $-364M | $-331M | $-300M | $-259M | $-196M | $-157M | $-124M | $-95M | $-60M | $-25M | $-17M | |
| AOCI | $-97.0K | $174.0K | $238.0K | $37.0K | $118.0K | $233.0K | $641.0K | $-280.0K | $-181.0K | $207.0K | $-262.0K | $-310.0K | $-307.0K | $-684.0K | $-855.0K | · | |
| Stockholders' Equity | $234M | $275M | $316M | $364M | $411M | $439M | $459M | $476M | $504M | $555M | $582M | $602M | $618M | $641M | $663M | $660M | |
| Liabilities + Equity | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | $694M | |
| Shares Outstanding | 80,027,099 | 78,126,796 | 78,126,796 | 81,137,478 | 85,579,475 | 84,463,059 | 84,463,059 | 84,422,000 | 84,223,100 | 83,435,513 | 83,435,513 | 83,399,377 | 83,399,377 | 83,287,639 | 83,287,639 | 83,257,591 |
Cash Flow 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $106.0K | $43.0K | |
| Stock-based Comp | $4M | $5M | $5M | $5M | $7M | $14M | $12M | $13M | $13M | $12M | $12M | $12M | $13M | $12M | $12M | $12M | |
| Operating Cash Flow | $-46M | $-28M | $-40M | $-33M | $-31M | $-30M | $-23M | $-42M | $-40M | $-22M | $-18M | $-16M | $-30M | $-22M | $-21M | $-19M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $20.0K | $2M | |
| Investing Cash Flow | $30M | $47M | $41M | $15M | $86M | $-3M | $-122M | $125M | $57M | $28M | $-59M | $47M | $24M | $33M | $-487M | $-2M | |
| Stock Repurchased | · | $0 | $11M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $257.0K | $0 | $-11M | $-14M | $-347.0K | $0 | $117.0K | $0 | $150.0K | $0 | $92.0K | $0 | $165.0K | $0 | $147.0K | $0 | |
| Net Change in Cash | $-16M | $18M | $-10M | $-32M | $55M | $-34M | $-145M | $82M | $17M | $6M | $-76M | $30M | $-5M | $12M | $-508M | $-21M |
Profitability 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.8% | · | -10.1% | -8.2% | -6.9% | · | -5.7% | -7.1% | -10.6% | · | -5.1% | -4.3% | -5.2% | · | -1.1% | -4.0% | |
| ROE | -14.1% | · | -10.9% | -8.8% | -7.5% | · | -6.0% | -7.5% | -11.2% | · | -5.3% | -4.5% | -5.5% | · | -1.3% | -5.0% | |
| ROIC | -20.6% | · | -14.5% | -11.4% | -9.6% | · | -8.2% | -9.9% | -13.9% | · | -7.1% | -5.9% | -6.8% | · | -1.7% | -4.9% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | · | 16.7 | 19.2 | 19.9 | · | 19.3 | 19.0 | 13.3 | · | 31.9 | 38.4 | 51.2 | · | 43.6 | 27.5 | |
| Quick Ratio | 2.4 | · | 3.8 | 4.4 | 5.5 | · | 3.9 | 9.1 | 3.9 | · | 7.3 | 13.2 | 14.8 | · | 11.6 | 27.3 |
Valuation (TTM) 7
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-159M | · | $-145M | $-143M | $-169M | · | $-168M | $-165M | $-160M | · | $-105M | $-103M | $-117M | · | $-110M | $-100M | |
| Market Cap | $431M | · | $227M | $292M | $256M | · | $283M | $279M | $340M | · | $250M | $312M | $279M | · | $474M | $591M | |
| P/E | -2.8 | · | -1.7 | -2.1 | -1.5 | · | -1.7 | -1.7 | -2.1 | · | -2.4 | -3.0 | -2.4 | · | -4.3 | -5.9 | |
| P/B | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.9 | |
| P / Tangible Book | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.9 | |
| P / Cash Flow | -9.3 | · | · | · | -8.4 | · | · | · | -8.5 | · | · | · | -9.4 | · | · | · | |
| Earnings Yield | -36.1% | · | -60.0% | -46.9% | -66.9% | · | -59.7% | -59.5% | -47.5% | · | -42.3% | -33.4% | -42.4% | · | -23.4% | -17.0% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $351M |
| Operating Margin % | — | — | — | — | 39.4% |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M |
| Diluted EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | — | — | $-123M | $-87M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.